作者: Robert T. Misson , Ralph E. Cutler
DOI:
关键词:
摘要: Review of the literature concerning contrast-induced renal dysfunction shows that currently used agents are remarkably safe with careful patient selection. Clinically apparent kidney failure after their use is essentially nonexistent in those without preexistent insufficiency. The incidence rises rapidly azotemia from any cause, however, and diabetic persons nephropathy perhaps at special risk. Vigorous volume expansion possibly effective as a preventive measure may attenuate adverse effects whom postcontrast occurs. New becoming available. It not yet known if these will prove safer or cost-effective. They have some experimentally demonstrated theoretical advantages over presently agents. 58 references, 1 figure, 2 tables.